200 related articles for article (PubMed ID: 7534787)
1. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking.
Chaouchi N; Vazquez A; Galanaud P; Leprince C
J Immunol; 1995 Apr; 154(7):3096-104. PubMed ID: 7534787
[TBL] [Abstract][Full Text] [Related]
2. Intracellular CD22 rapidly moves to the cell surface in a tyrosine kinase-dependent manner following antigen receptor stimulation.
Sherbina NV; Linsley PS; Myrdal S; Grosmaire LS; Ledbetter JA; Schieven GL
J Immunol; 1996 Nov; 157(10):4390-8. PubMed ID: 8906814
[TBL] [Abstract][Full Text] [Related]
3. Association of CD22 with the B cell antigen receptor.
Peaker CJ; Neuberger MS
Eur J Immunol; 1993 Jun; 23(6):1358-63. PubMed ID: 7684686
[TBL] [Abstract][Full Text] [Related]
4. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties.
Carnahan J; Wang P; Kendall R; Chen C; Hu S; Boone T; Juan T; Talvenheimo J; Montestruque S; Sun J; Elliott G; Thomas J; Ferbas J; Kern B; Briddell R; Leonard JP; Cesano A
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3982S-90S. PubMed ID: 14506197
[TBL] [Abstract][Full Text] [Related]
5. B cell antigen receptor-evoked calcium influx is enhanced in CD22-deficient B cell lines.
Nadler MJ; McLean PA; Neel BG; Wortis HH
J Immunol; 1997 Nov; 159(9):4233-43. PubMed ID: 9379018
[TBL] [Abstract][Full Text] [Related]
6. Constitutive endocytosis and degradation of CD22 by human B cells.
Shan D; Press OW
J Immunol; 1995 May; 154(9):4466-75. PubMed ID: 7722303
[TBL] [Abstract][Full Text] [Related]
7. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
Bonardi MA; French RR; Amlot P; Gromo G; Modena D; Glennie MJ
Cancer Res; 1993 Jul; 53(13):3015-21. PubMed ID: 7686448
[TBL] [Abstract][Full Text] [Related]
8. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
Kansas GS; Tedder TF
J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
[TBL] [Abstract][Full Text] [Related]
9. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
Koníková E; Kusenda J; Babusíková O; Glasová M
Neoplasma; 1995; 42(5):227-34. PubMed ID: 8552200
[TBL] [Abstract][Full Text] [Related]
10. A bispecific recombinant immunotoxin, DT2219, targeting human CD19 and CD22 receptors in a mouse xenograft model of B-cell leukemia/lymphoma.
Vallera DA; Todhunter DA; Kuroki DW; Shu Y; Sicheneder A; Chen H
Clin Cancer Res; 2005 May; 11(10):3879-88. PubMed ID: 15897589
[TBL] [Abstract][Full Text] [Related]
11. Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking.
Sumimoto S; Heike T; Kanazashi S; Shintaku N; Jung EY; Hata D; Katamura K; Mayumi M
J Immunol; 1994 Sep; 153(6):2488-96. PubMed ID: 7521364
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
13. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of the B cell-restricted molecule CD22 on neonatal B lymphocytes depending upon antigen stimulation.
Viemann D; Schlenke P; Hammers HJ; Kirchner H; Kruse A
Eur J Immunol; 2000 Feb; 30(2):550-9. PubMed ID: 10671211
[TBL] [Abstract][Full Text] [Related]
15. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
16. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H
Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932
[TBL] [Abstract][Full Text] [Related]
17. Differential regulatory effects of cAMP-elevating agents on human normal and neoplastic B cell functional response following ligation of surface immunoglobulin and CD40.
Kelly K; Knox KA
Cell Immunol; 1995 Nov; 166(1):93-102. PubMed ID: 7585986
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C.
Campbell MA; Klinman NR
Eur J Immunol; 1995 Jun; 25(6):1573-9. PubMed ID: 7542197
[TBL] [Abstract][Full Text] [Related]
19. SLP-76 is recruited to CD22 and dephosphorylated by SHP-1, thereby regulating B cell receptor-induced c-Jun N-terminal kinase activation.
Mizuno K; Tagawa Y; Watanabe N; Ogimoto M; Yakura H
Eur J Immunol; 2005 Feb; 35(2):644-54. PubMed ID: 15668918
[TBL] [Abstract][Full Text] [Related]
20. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion.
Stamenkovic I; Seed B
Nature; 1990 May; 345(6270):74-7. PubMed ID: 1691828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]